[3-(dimethylamino)propyl]thiourea, 95.0%, 1g

5-Methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-6-amine, 100mg

N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoyl)-D-lysine, 98+%, 100mg

1-[(3-chloro-4-fluorophenyl)methyl]-1H-pyrazol-4-amine, 95.0%, 2g

(S)-2-((tert-Butoxycarbonyl)(ethyl)amino)propanoic acid, 98%, 1g

2-(tert-Butyl) 4-ethyl 5-amino-3-methylthiophene-2,4-dicarboxylate, 97%, 1g

3-Amino-4-cyclobutyl-2-hydroxybutanamide Hydrochloride (mixture of diastereoisomers)>95.0%(T)250mg

3,5-Dimethoxypyridine hydrochloride, 97%, 500mg

4-(6-Oxo-1,6-dihydropyridazin-3-yl)benzoic acid, 95%, 250mg

4-Dimethylaminoazobenzene-4'-carboxylic acid, 95.0%, 100g

4-(3-((4-Chloro-7-methoxyquinazolin-6-yl)oxy)propyl)morpholine, 95+%, 5g

Iron powder, min. 99.5% pa, approx. 10 µm, 250 g, plastic packaging.

Cyclohexanone-4-carboxaldehyde, 95.0%, 250mg